학술논문
P- 40 PENTOXIFYLLINE USE IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS ADMITTED WITH ACUTE KIDNEY INJURY COULD DECREASE SURVIVAL: A GLOBAL STUDY
Document Type
Article
Author
Idalsoaga, Francisco; Diaz, Luis Antonio; Corsi, Oscar; Ayares, Gustavo; Arnold, Jorge; Dunn, Winston; Li, Yanming; Singal, Ashwani; Simonetto, Doug; Ayala-Valverde, María; Ramirez, Carolina A; Morales-Arraez, Dalia; Zhang, Wei; Qian, Steve; Ahn, Joseph; Buryska, Seth; Mehta, Heer; Waleed, Muhammad; Stefanescu, Horia; Horhat, Adelina; Bumbu, Andreea; Agrawal, Bashar; Agrawal, Rohit; Cabezas, Joaquín; Cuyàs, Berta; Poca, Maria; Pastor, German Soriano; Sarin, Shiv K; Maiwall, Rakhi; Jalal, Prasun K; Tijera, María Fátima Higuera-De La; Kulkarni, Anand; Rao, Nagaraja; Salazar, Patricia Guerra; Skladaný, Lubomir; Bystrianska, Natália; Prado, Veronica; Clemente-Sanchez, Ana; Rincón, Diego; Haider, Tehseen; Chacko, Kristina R; Romero, Gustavo A; Pollarsky, Florencia; Restrepo, Juan Carlos; Toro, Luis G; Yaquich, Pamela; Mendizabal, Manuel; Garrido, Maria Laura; Marciano, Sebastian; Dirchwolf, Melisa; Vargas, Victor; Jimenez, Cesar; García-Tsao, Guadalupe; Ortiz, Guillermo; Abraldes, Juan G; Kamath, Patrick; Shah, Vijay; Bataller, Ramon; Arab, Juan Pablo
Source
Annals of Hepatology; February 2024, Vol. 29 Issue: 1, Number 1 Supplement 1
Subject
Language
ISSN
16652681
Abstract
Alcohol-associated hepatitis (AH) is a severe entity with a mortality of up to 30–50% at 1 month. Pentoxifylline combined with steroids has not demonstrated benefits in severe AH. Some studies have suggested that pentoxifylline may be beneficial in the subgroup of patients with acute kidney injury (AKI) and AH. However, there is no solid evidence of its benefit in mortality in this setting. This study aimed to determine the benefit of the use of pentoxifylline in patients with severe AH and AKI.